Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage Secondary to Diabetic Retinopathy

NCT01091896 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT01091896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01091896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjuvant Intravitreal Bevacizumab in Pars Plana Vitrectomy for Vitreous Hemorrhage Secondary to Diabetic Retinopathy
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Unknown status
Start date
January 31, 2010
Completion date
March 31, 2011
Enrollment
1 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vitreous hemorrhage secondary to pdr